MoneyWorks4Me

Guj. Themis Biosyn - Quaterly Results

14 May 2024 Evaluate
The turnover zoomed to Rs. 420.11 millions, up 52.30% for the March 2024 quarter as against Rs. 275.85 millions during the year-ago period.A comparatively good net profit growth of 35.88% to Rs. 158.86 millions was reported for the quarter ended March 2024 compared to Rs. 116.91 millions of previous same quarter.OP of the company witnessed a marginal growth to 219.49 millions from 163.24 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 420.11 275.85 52.30 1698.22 1483.85 14.45 1698.22 1483.85 14.45
Other Income 10.18 19.62 -48.11 43.66 65.88 -33.73 43.66 65.88 -33.73
PBIDT 219.49 163.24 34.46 831.00 802.17 3.59 831.00 802.17 3.59
Interest 0.75 0.25 200.00 2.29 1.76 30.11 2.29 1.76 30.11
PBDT 218.74 162.99 34.20 828.71 800.41 3.54 828.71 800.41 3.54
Depreciation 9.25 7.69 20.29 35.36 25.76 37.27 35.36 25.76 37.27
PBT 209.49 155.30 34.89 793.35 774.65 2.41 793.35 774.65 2.41
TAX 50.63 38.39 31.88 201.71 194.96 3.46 201.71 194.96 3.46
Deferred Tax 0.97 0.05 1840.00 3.75 2.55 47.06 3.75 2.55 47.06
PAT 158.86 116.91 35.88 591.64 579.69 2.06 591.64 579.69 2.06
Equity 72.64 72.64 0.00 72.64 72.64 0.00 72.64 72.64 0.00
PBIDTM(%) 52.25 59.18 -11.71 48.93 54.06 -9.48 48.93 54.06 -9.48
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..